Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,667 total articles

UBS Lowers Rating on 1&1 AG to Neutral as Stock Nears Bank Valuation

UBS Lowers Rating on 1&1 AG to Neutral as Stock Nears Bank Valuation

UBS has downgraded 1&1 AG from buy to neutral and slightly reduced its price target to €27.6, arguing that the stock at roughly €26.75 already reflects an expectation of a curtailed mobile network build and a related improvement in free cash flow. The bank outlines a path to positive cash generation if 1&1 limits coverage ambitions, but warns of co…

TSX Futures Edge Up as Markets Brace for Packed U.S. Data Calendar

TSX Futures Edge Up as Markets Brace for Packed U.S. Data Calendar

Futures on Canada’s principal stock gauge inched higher Tuesday as investors positioned ahead of a heavy U.S. economic calendar. Gains in the materials sector, helped by firmer gold, supported the S&P/TSX, while U.S. futures were largely subdued as the market awaited corporate results and rescheduled labor and inflation data. Oil advanced on geopol…

UBS Cuts Ionos Rating, Flags AI Threats and Near-Term Revenue Weakness

UBS Cuts Ionos Rating, Flags AI Threats and Near-Term Revenue Weakness

UBS downgraded German web hosting provider Ionos SE to neutral from buy and reduced its price target to €28 from €40. The brokerage cited persistent risks from AI-enabled website builders that could undermine Ionos' Web Presence and Productivity segment, alongside expectations for slowing revenue growth into 2025 and 2026.

HealthLynked Files for $7 Million Share Offering and Seeks NASDAQ Listing

HealthLynked Files for $7 Million Share Offering and Seeks NASDAQ Listing

HealthLynked Corp. has filed to raise up to $7 million through a public offering of common stock and has applied to list its shares on the NASDAQ Capital Market. The company plans an assumed share price range of $4.00 to $6.00 and currently trades on the OTCQB at $2.75 per share as of February 6, 2026. HealthLynked said the final offering price wil…

Berenberg Lowers E.ON Rating to Hold Citing Regulatory Ambiguity in Germany

Berenberg Lowers E.ON Rating to Hold Citing Regulatory Ambiguity in Germany

Berenberg downgraded E.ON SE to "hold" from "buy," pointing to recent share appreciation that has brought the stock close to the broker's raised price target and to ongoing uncertainty around Germany's regulatory framework for networks. The bank says E.ON is well placed financially to expand network investment but needs clearer, supportive regulato…

4basebio names Dr Amy Walker as CEO in management reshuffle

4basebio names Dr Amy Walker as CEO in management reshuffle

4basebio PLC has elevated its chief operating officer, Dr Amy Walker, to the role of chief executive officer. The move accompanies a reorganization in which outgoing CEO Dr Heikki Lanckriet will stay on the company board while separating the Hermes nanoparticle-based DNA delivery platform into a standalone, separately-funded therapeutics business. …

SoftBank Poised to Log OpenAI Gain as Markets Turn Attention to How It Will Fund Further AI Investments

SoftBank Poised to Log OpenAI Gain as Markets Turn Attention to How It Will Fund Further AI Investments

SoftBank Group is expected to report a significant investment gain related to its stake in OpenAI when it publishes quarterly results, but market focus is shifting to how the Japanese investment firm will bankroll additional AI commitments. Heavy exposure to a money-losing OpenAI has increased concentration risk and raised questions about SoftBank'…